4-methoxyamphetamine has been researched along with Hypertrophy, Left Ventricular in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canichella, F; Citoni, B; Ferrucci, A; Figliuzzi, I; Miceli, F; Presta, V; Tocci, G; Volpe, M | 1 |
| Chang, YK; Cho, JS; Cho, WK; Hong, YA; Hwang, HS; Kim, SY; Kim, Y; Yang, CW; Yoon, HE | 1 |
| Aurigemma, GP; Bang, CN; Boman, K; Dahlöf, B; de Simone, G; Devereux, RB; Gerdts, E; Køber, L; Wachtell, K | 1 |
| Birner, C; Dietl, A; Heid, IM; Luchner, A; Maier, LS; Meisinger, C; Peters, A; Schunkert, H; Stark, K; Zimmermann, ME | 1 |
| Ayers, CR; Berry, JD; de Lemos, JA; deFilippi, C; Drazner, MH; McGuire, DK; Nambi, V; Neeland, IJ; Omland, T; Seliger, SL | 1 |
| Ho, PY; Sanderson, JE; Tse, MK; Wang, AY; Wang, M; Yip, GW; Yu, CM; Zhang, Y | 1 |
| Egstrup, K; Møller, JE; Poulsen, SH; Søndergaard, E | 1 |
1 review(s) available for 4-methoxyamphetamine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Conventional and new electrocardiographic criteria for hypertension-mediated cardiac organ damage: A narrative review.
Topics: Aorta; Cardiovascular Diseases; Cost-Benefit Analysis; Death; Dilatation, Pathologic; Early Diagnosis; Electrocardiography; Female; Heart; Heart Failure; Heart Failure, Diastolic; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Mass Screening; Myocardial Infarction; Narration; Practice Patterns, Physicians'; Risk Assessment; Risk Factors; Stroke | 2019 |
1 trial(s) available for 4-methoxyamphetamine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antihypertensive Agents; Atenolol; Cause of Death; Death; Echocardiography, Doppler; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Myocardial Infarction; Organ Size; Proportional Hazards Models; Stroke | 2014 |
5 other study(ies) available for 4-methoxyamphetamine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Retinopathy and left ventricular hypertrophy in patients with chronic kidney disease: Interrelationship and impact on clinical outcomes.
Topics: Aged; Aged, 80 and over; Death; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Hypertensive Retinopathy; Hypertrophy, Left Ventricular; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Treatment Outcome | 2017 |
NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up.
Topics: Death; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Natriuretic Peptide, Brain; Organ Size; Peptide Fragments; Ventricular Function, Left | 2016 |
Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.
Topics: Adult; Biomarkers; Cohort Studies; Death; Female; Follow-Up Studies; Heart Failure; Heart Injuries; Heart Ventricles; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Phenotype; Prevalence; Risk Factors; Troponin T | 2013 |
Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy.
Topics: Aged; Blood Flow Velocity; Cohort Studies; Death; Diastole; Echocardiography, Doppler; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Mitral Valve; Predictive Value of Tests; Prevalence; Prognosis; Survival Analysis; Ventricular Dysfunction, Left | 2005 |
The Doppler echocardiographic myocardial performance index predicts left-ventricular dilation and cardiac death after myocardial infarction.
Topics: Aged; Death; Echocardiography, Doppler; Humans; Hypertrophy, Left Ventricular; Middle Aged; Mitral Valve Insufficiency; Multivariate Analysis; Myocardial Infarction; Prognosis; Regression Analysis; Reproducibility of Results | 2001 |